Literature DB >> 26608293

Comet Assay in Cancer Chemoprevention.

Raffaela Santoro1, Maria Ferraiuolo2, Gian Paolo Morgano3, Paola Muti4, Sabrina Strano5,6.   

Abstract

The comet assay can be useful in monitoring DNA damage in single cells caused by exposure to genotoxic agents, such as those causing air, water, and soil pollution (e.g., pesticides, dioxins, electromagnetic fields) and chemo- and radiotherapy in cancer patients, or in the assessment of genoprotective effects of chemopreventive molecules. Therefore, it has particular importance in the fields of pharmacology and toxicology, and in both environmental and human biomonitoring. It allows the detection of single strand breaks as well as double-strand breaks and can be used in both normal and cancer cells. Here we describe the alkali method for comet assay, which allows to detect both single- and double-strand DNA breaks.

Entities:  

Keywords:  Comet assay; DNA damage; DNA repair; Double-strand breaks (DSB); Genotoxic stress; Single-cell gel electrophoresis (SCGE); Single-strand breaks (SSB)

Mesh:

Year:  2016        PMID: 26608293     DOI: 10.1007/978-1-4939-3191-0_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  The Influence of Radiotherapy on AIM2 Inflammasome in Radiation Pneumonitis.

Authors:  Qianyu Zhang; Qinyong Hu; Yuxin Chu; Bin Xu; Qibin Song
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

Review 2.  The various aspects of genetic and epigenetic toxicology: testing methods and clinical applications.

Authors:  Ning Ren; Manar Atyah; Wan-Yong Chen; Chen-Hao Zhou
Journal:  J Transl Med       Date:  2017-05-22       Impact factor: 5.531

3.  Combined pretreatment with 18F-FDG PET/CT and Comet assay guides the concurrent chemoradiotherapy of locally advanced cervical cancer: study protocol for a randomized controlled trial.

Authors:  Shengjun Ji; Qunchao Hu; Jiahao Zhu; Jie Chen; Qingqing Chen; Zhengcao Liu; Chen Shen; Ru Yang; Haoyao Sun; Jinchang Wu; Ke Gu
Journal:  Trials       Date:  2018-08-03       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.